Clear aligners work for simple cases. The concern is the mail-order model

Clear aligners are effective at straightening mild-to-moderate crowding and spacing, but their predictability drops sharply for certain tooth movements, and the evidence-based concern with mail-order kits is not the aligners themselves but the loss of in-person diagnosis and monitoring [s1][s2][s3]. The plastic trays move teeth the same way whether prescribed in an office or shipped from a lab; what changes with the direct-to-consumer model is the clinical oversight around them [s3].

What the aligners can and cannot do

A systematic review of Invisalign treatment concluded, despite heterogeneous studies, that the system is a viable alternative to fixed braces for correcting mild-to-moderate malocclusions in non-growing patients — a carefully bounded endorsement, not a claim of equivalence for all cases [s2]. A separate review quantifying accuracy found that aligners handled some movements well and others poorly: extrusion was the most difficult movement to control, achieved with about 30% accuracy, and rotation of rounded teeth was also unreliable, while upper-molar distalization reached 88% predictability and anterior intrusion was well controlled [s1].

Those numbers explain the standard clinical division: aligners are a reasonable tool for straightforward alignment and relapse, but complex problems — large rotations, teeth that need to be pulled down or up (extrusion), significant bite corrections — are where they underperform and where they most need supplementary attachments or a different appliance altogether [s1]. The predictability figures are averages from planned-versus-achieved comparisons, so an individual result depends on the case and the planning [s1].

The direct-to-consumer question

The safety debate centres on the mail-order model, in which a patient takes their own impressions or scan and receives aligners without an in-person examination or ongoing supervision [s3]. Orthodontic bodies have issued consumer alerts warning that this bypasses steps that catch problems before treatment: a clinical exam and X-rays that detect gum disease, decay, root or bone conditions, and the periodic monitoring that spots teeth moving in unintended ways [s3]. The concern is that moving teeth is a medical procedure with the potential for harm — including irreversible damage to roots or supporting bone — if underlying disease is missed or movement goes unmonitored [s3].

That concern is about process risk rather than a proven rate of harm; the aligner material and the general approach are the same as supervised treatment, but the safeguards differ [s3]. The largest direct-to-consumer aligner company ceased operations in 2023, which removed the most prominent example but did not resolve the underlying question about unsupervised care [s3].

The limits of the evidence

The effectiveness studies are dominated by treatment delivered under professional supervision, so they cannot be read as validating unsupervised mail-order use [s1][s2]. The predictability review pools varied study designs and the accuracy percentages carry real uncertainty [s1]. And the safety case against direct-to-consumer models rests substantially on professional-body warnings and the rationale for pre-treatment screening rather than on large comparative outcome trials, which do not exist [s3].

The defensible summary: for simple alignment in a healthy mouth, aligners are an evidence-supported option; for complex movement they are less reliable; and for any case, skipping the in-person diagnosis and monitoring is the part the evidence and professional guidance most caution against [s1][s2][s3]. This is informational reporting, not dental advice.